We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOC
1101
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.5M | 0.01% |
343,001
+18,129
| +6% | +$332K |
|
|
THS
1102
DELISTED
Treehouse Foods
THS
| $6.5M | 0.01% |
133,912
+319
| +0.2% | +$16.3K |
|
|
LSXMK
1103
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $6.48M | 0.01% |
176,765
+1,484
| +0.8% | +$51.8K |
|
1104
eHealth
EHTH
$45.1M
| $6.48M | 0.01% |
67,434
+4,802
| +8% | +$373K |
|
1105
Westamerica Bancorp
WABC
$1.39B
| $6.48M | 0.01% |
95,577
+5,475
| +6% | +$358K |
|
|
PFPT
1106
DELISTED
Proofpoint, Inc.
PFPT
| $6.47M | 0.01% |
56,404
+1,367
| +2% | +$163K |
|
1107
Terreno Realty
TRNO
$7.44B
| $6.47M | 0.01% |
119,505
+11,570
| +11% | +$632K |
|
1108
Ryman Hospitality Properties
RHP
$8.09B
| $6.46M | 0.01% |
74,573
+5,647
| +8% | +$486K |
|
1109
Evertec
EVTC
$2.01B
| $6.44M | 0.01% |
189,229
+12,121
| +7% | +$384K |
|
1110
Olin
OLN
$2.17B
| $6.43M | 0.01% |
372,960
-6,794
| -2% | -$122K |
|
1111
Werner Enterprises
WERN
$2.3B
| $6.4M | 0.01% |
175,920
+6,361
| +4% | +$233K |
|
1112
Healthcare Realty
HR
$7.02B
| $6.39M | 0.01% |
211,061
+16,272
| +8% | +$486K |
|
|
CHX
1113
DELISTED
ChampionX
CHX
| $6.37M | 0.01% |
188,614
-6,527
| -3% | -$178K |
|
1114
Horace Mann Educators
HMN
$2.1B
| $6.37M | 0.01% |
145,877
+8,644
| +6% | +$382K |
|
1115
Kontoor Brands
KTB
$4.61B
| $6.37M | 0.01% |
151,599
+9,601
| +7% | +$363K |
|
1116
Compass Minerals
CMP
$1.25B
| $6.36M | 0.01% |
104,381
+4,501
| +5% | +$255K |
|
1117
Chegg
CHGG
$115M
| $6.36M | 0.01% |
167,768
+13,643
| +9% | +$477K |
|
1118
Pacira BioSciences
PCRX
$1.09B
| $6.35M | 0.01% |
140,200
+12,684
| +10% | +$539K |
|
|
GLIBA
1119
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $6.33M | 0.01% |
89,322
+823
| +0.9% | +$56.6K |
|
1120
Under Armour Class C
UA
$2.86B
| $6.32M | 0.01% |
329,654
+17,983
| +6% | +$316K |
|
1121
Fluor
FLR
$7.2B
| $6.32M | 0.01% |
334,737
+459
| +0.1% | +$8.34K |
|
1122
Keurig Dr Pepper
KDP
$42.3B
| $6.32M | 0.01% |
218,118
+934
| +0.4% | +$26.8K |
|
1123
HubSpot
HUBS
$12.7B
| $6.31M | 0.01% |
39,821
+972
| +3% | +$149K |
|
1124
Walker & Dunlop
WD
$1.78B
| $6.31M | 0.01% |
97,574
+5,352
| +6% | +$339K |
|
|
DEA
1125
Easterly Government Properties
DEA
$1.18B
| $6.31M | 0.01% |
106,348
+11,186
| +12% | +$631K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.